Testing effectiveness (Phase 2)Active Not RecruitingNCT06549257
What this trial is testing
Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant
Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 56